First human case of co-infection with two different subtypes of hepatitis e virus

Intervirology

Volumn 55, Issue 6, 2012, Pages 484-487

  Moal, Valrie ^a   Gerolami, René ^b   Colson, Philippe ^c,d  

^a HÔPITAL DE LA CONCEPTION   (France)

^b Hopital Conception   (France)

^c TIMONE HOSPITAL   (France)

^d CNRS   (France)

Author keywords

Acute hepatitis; Genotype 3; Hepatitis E virus; Immunosuppression; Solid organ transplant

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ACUTE HEPATITIS; AGED; ARTICLE; CASE REPORT; ECHOGRAPHY; FOOD INTAKE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIXED INFECTION; OPEN READING FRAME; PHYLOGENETIC TREE; PIG LIVER SAUSAGE; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS STRAIN; VIRUS TRANSMISSION;

AGED; COINFECTION; GALLSTONES; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; PHYLOGENY; RNA, VIRAL;

HEPATITIS E VIRUS; SUIDAE;

EID: 84867234299     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000335664     Document Type: Article

References (20)

1. Purcell RH, Emerson SU: Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
2. Lu L, Li C, Hagedorn CH: Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16: 5-36.
3. Legrand-Abravanel F, Mansuy JM, Dubois M, et al: Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009; 15: 110-114.
4. Kamar N, Selves J, Mansuy JM, et al: Hepatitis E virus and chronic hepatitis in organtransplant recipients. N Engl J Med 2008; 358: 811-817.
5. Gérolami R, Moal V, Colson P: Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-860.
6. Pischke S, Suneetha PV, Baechlein C, et al: Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16: 74-82.
7. Haagsma EB, Niesters HGM, van den Berg AP, et al: Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15: 1225-1228.
8. Mansuy JM, Bendall R, Legrand-Abravanel F, et al: Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17: 2309-2312.
9. Kaba M, Davoust B, Marié JL, et al: Detection of hepatitis E virus in wild boar (Sus scrofa) livers. Vet J 2010; 186: 259-261.
10. Colson P, Borentain P, Queyriaux B, et al: Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202: 825-834.
11. Takahashi M, Nishizawa T, Yoshikawa A, et al: Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J Gen Virol 2002; 83: 1931-1940.
12. Colson P, Moal V, Borentain P, et al: Seroprevalence and outcome of hepatitis E infection in organ transplanted patients (abstract). Hepatology 2008; 50:s732A.
13. Li Z, Yu S, Dong S, et al: Reduced prevalence of genotype 3 HEV in Shanghai pig farms and hypothetical homeostasis of porcine HEV reservoir. Vet Microbiol 2009; 137: 184-189.
14. Purdy MA, Khudyakov YE: Evolutionary history and population dynamics of hepatitis E virus. PLoS One 2010; 5:e14376.
15. Grandadam M, Tebbal S, Caron M, et al: Evidence for hepatitis E virus quasispecies. J Gen Virol 2004; 85: 3189-3194.
16. Kamar N, Abravanel F, Selves J, et al: Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89: 353-360.
17. Colson P, Dhiver C, Poizot-Martin I, et al: Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 2011; 18: 227-228.
18. Alric L, Bonnet D, Laurent G, et al: Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-therapy. Ann Intern Med 2010; 153: 135-136.
19. Covic A, Abramowicz D, Bruchfeld A, et al: Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719-727.
20. Kamar N, Rostaing L, Abravanel F, et al: Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139: 1612-1618.